Home/NeuroVision Imaging/Leyla Anderson, MD, PhD, D(ABMLI)
LA

Leyla Anderson, MD, PhD, D(ABMLI)

VP, Biomarker Development

NeuroVision Imaging

NeuroVision Imaging Pipeline

DrugIndicationPhase
Afina Retinal ImagingAlzheimer's Disease DiagnosisValidation/Development
Afina for CAA/ARIA PredictionCerebral Amyloid Angiopathy / ARIA Risk StratificationValidation/Development
BrainHealth Telehealth PlatformCognitive Impairment Care DeliveryCommercial
Biomarker Development ProgramNeurological DisordersResearch